SCHEMBL3799059

SCHEMBL3799059

Nc1ccccc1OC1CCCCC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 2/20 0.53
KDM4E B2RXH2 2/20 0.47
MAPT P10636 2/20 0.47
GAA P10253 1/20 0.47
CARM1 Q86X55 3/20 0.47
PRMT1 Q99873 3/20 0.47
ALDH1A1 P00352 2/20 0.43
ADRA2B P18089 1/20 0.43
PTGS1 P23219 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
CSNK2A1 P68400 2/20 0.40
HRH1 P35367 1/20 0.40
PDE4A P27815 2/20 0.39
PDE5A O76074 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4C Q08493 1/20 0.39
PDE4D Q08499 1/20 0.39
CRHBP P24387 1/20 0.38
CRHR2 Q13324 1/20 0.38
FABP7 O15540 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29527476 1.00 MCHR1 (0.53) MCHR1KDM4EMAPTGAACARM1
SCHEMBL1134126 0.98 MCHR1 (0.50) MCHR1KDM4EMAPTGAACARM1
SCHEMBL6905082 0.90 ALDH1A1 (0.48) MCHR1KDM4EMAPTGAAALDH1A1
SCHEMBL2242864 0.85 MCHR1 (0.51) MCHR1CARM1PRMT1ADRA2BCSNK2A1
SCHEMBL5344402 0.83 MCHR1 (0.49) MCHR1CARM1PRMT1ADRA2BCSNK2A1
Aniline SCHEMBL22169159 0.82 ALDH1A1 (0.42) MCHR1KDM4EMAPTALDH1A1ADRA2B
SCHEMBL22684133 0.82 MCHR1 (0.51) MCHR1KDM4EMAPTGAACARM1
SCHEMBL13537844 0.82 MCHR1 (0.51) MCHR1KDM4EMAPTGAACARM1
SCHEMBL3798831 0.81 KAT2B (0.53) MCHR1KDM4EMAPTALDH1A1ADRA2B
SCHEMBL9505634 0.81 HRH1 (0.41) MCHR1KDM4EMAPTGAACARM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108409684-B N- (2-cyclohexyloxyphenyl) amide compound and preparation method and application thereof 上海晓明检测技术服务有限公司 2022-04-12 CN claimed
CN-108409684-B N- (2-cyclohexyloxyphenyl) amide compound and preparation method and application thereof 上海晓明检测技术服务有限公司 2022-04-12 CN disclosed
CN-108409684-B N- (2-cyclohexyloxyphenyl) amide compound and preparation method and application thereof 上海晓明检测技术服务有限公司 2022-04-12 CN disclosed
CN-108409684-B N- (2-cyclohexyloxyphenyl) amide compound and preparation method and application thereof 上海晓明检测技术服务有限公司 2022-04-12 CN disclosed
US-20100143341-A1 THIENOPYRIMIDINES FOR PHARMACEUTICAL COMPOSITIONS DEVELOGEN AKTIENGESELLSCHAFT (DE) 2010-06-10 US disclosed
EP-1899353-A1 THIENOPYRIMIDINES FOR PHARMACEUTICAL COMPOSITIONS DeveloGen Aktiengesellschaft (DE) 2008-03-19 EP disclosed
WO-2007059905-A9 THIENOPYRIMIDINES TREATING INFLAMMATORY DISEASES DEVELOGEN AG (DE) 2007-11-01 WO disclosed
WO-2007059905-A2 THIENOPYRIMIDINES TREATING INFLAMMATORY DISEASES DEVELOGEN AKTIENGESELLSCHAFT (DE) 2007-05-31 WO disclosed
WO-2006136402-A1 THIENOPYRIMIDINES FOR PHARMACEUTICAL COMPOSITIONS DEVELOGEN AKTIENGESELLSCHAFT (DE) 2006-12-28 WO disclosed
EP-0848703-B1 DERIVATIVES OF BENZOSULPHONAMIDES AS INHIBITORS OF THE ENZYME CYCLO-OXYGENASE II NYCOMED AUSTRIA GMBH (AT) 2000-09-27 EP disclosed
US-6004948-A NON-STEROIDAL ANTIINFLAMMATORY AGENTS; SIDE EFFECT REDUCTION NYCOMED AUSTRIA GMBH (AT) 1999-12-21 US disclosed
EP-0848703-A1 DERIVATIVES OF BENZOSULPHONAMIDES AS INHIBITORS OF THE ENZYME CYCLO-OXYGENASE II Nycomed Austria GmbH (AT) 1998-06-24 EP disclosed
EP-0623113-B1 PYRAZOLE CARBOXANILIDE FUNGICIDES MONSANTO CO (US) 1997-03-05 EP disclosed
WO-1997003953-A1 DERIVATIVES OF BENZOSULPHONAMIDES AS INHIBITORS OF THE ENZYME CYCLO-OXYGENASE II NYCOMED AUSTRIA GMBH (AT) 1997-02-06 WO disclosed
US-5223526-A For plants MONSANTO COMPANY (US) 1993-06-29 US disclosed
WO-1993011117-A1 PYRAZOLE CARBOXANILIDE FUNGICIDES MONSANTO COMPANY (US) 1993-06-10 WO disclosed
EP-0317332-B1 SULFONANILIDE COMPOUNDS TAISHO PHARMACEUTICAL CO. LTD (JP) 1993-05-19 EP disclosed
US-4885367-A ANTIINFLAMMATORY AGENTS, ANTIPYRETICS, ANALGESICS; SIDE EFFECT REDUCTION TAISHO PHARMACEUTICAL CO., LTD. (JP) 1989-12-05 US disclosed
EP-0317332-A2 Sulfonanilide compounds TAISHO PHARMACEUTICAL CO. LTD (JP) 1989-05-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100143341-A1 THIENOPYRIMIDINES FOR PHARMACEUTICAL COMPOSITIONS DTYMK, CMPK1, PDXK MCHR1 4661/4885KDM4E 2624/4885MAPT 2500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.